A global network of clinicians, academics and advocates dedicated to the elimination of mother to child transmission of syphilis.

University College Dublin & Childrens Health Ireland Crumlin and Temple St University Hospitals, Dublin, Ireland. Department of Paediatrics, Kamuzu University of Health Sciences.

Bridget Freyne is a paediatric infection disease specialist with a long standing interest in the management of congenital infections and particularly syphilis. She has extensive research experience in Europe and Malawi where she studied the effects of STI including syphilis on adverse outcomes and the use of rapid POCT in the diagnosis of gestational and congenital syphilis. She is the Chief Investigator of the CARES-1 clinical trial which will assess the PK and safety of oral amoxicillin and linezolid for the treatment of asymptomatic congenital syphilis in Malawi, South Africa and Indonesia

London School of Hygiene and Tropical Medicine) & University College London Hospital, London, United Kingdom

Michael is Professor of Medicine at LSHTM and an adult infectious diseases clinician. He is involved in leading a portfolio of studies focused on improving control of syphilis including diagnostics, genomics and treatment trials.

Tygerberg Hospital & Stellenbosch University, Cape Town, South Africa: 

Lisa Frigati is a paediatric infectious disease specialist at Tygerberg Hospital in Cape Town South Africa and an associate professor at Stellenbosch University. She has twenty years of experience in infectious diseases in resource limited setting and has a special interest in congenital infections.

University of Sydney, Australia

Phoebe is a consultant in paediatric infectious diseases at Sydney Children’s Hospital and an NHMRC Fellow at The University of Sydney, leading a consortium across Southeast Asia (www.neoseap.com) working to reduce the burden of antibiotic resistance, and improve the prevention and management of infections in newborn babies.

Imperial College Healthcare NHS Trust, and Imperial College

I am a consultant in paediatric infectious diseases at Imperial College Healthcare NHS Trust and Professor of Practice at Imperial College. I lead the congenital infection clinics at St Mary’s Hospital, London.  In 2020, with colleagues from around Europe, we set up CCMVNET ccmvnet@gmail.com an international network built around a prospective registry for children with congenital CMV (CCMV). I am a member of the Paediatric European Infection Network (PENTA-ID) and have participated in many HIV treatment and prevention trials for children. I have been actively involved in education for Paediatric Infections for many years, working with PENTA and the European Society for paediatric Infectious Diseases (ESPID).

Universidade Federal do Rio de Janeiro

I am a professor of Infectious Diseases at the Universidade Federal do Rio de Janeiro Medical School. I work as a physician in the infectious diseases pediatrics and pregnant women clinic, leading the congenital infectious diseases clinic.  I am a member of the Paediatric European Infection Network (PENTA-ID):I participate on the network and engagement committee and pregnancy and vertical transmission working group. I am a voting member of the International Maternal Pediatric and Adolescent AIDS Clinical Trial network (IMPAACT)  treatment committee, and the principal investigator of the Universidade Federal do Rio de Janeiro IMPAACT site. I am involved for several years in clinical practice and research on congenital infection, including syphilis.

University of Indonesia, Cipto Mangunkusumo Hospital, Indonesia

Nina is consultant of pediatric and tropical infections at Cipto Mangunkusumo Hospital, national referral hospital in Indonesia and lecturer at University of Indonesia. I am working mostly in neonatal infection and leading the Neocol project in Indonesia. My aim is to help reduce neonatal mortality through providing evidence for infection prevention and management.

Murdoch Children’s Research Institute; University of Melbourne 

A/Prof Amanda Gwee is the Leader of the Antimicrobials Group at Murdoch Children's Research Institute. She is a general paediatrician, infectious diseases physician, clinical pharmacologist, and Clinical Lead of Research in the Department of General Medicine at The Royal Children’s Hospital Melbourne. In addition, she is an Associate Professor in the Department of Paediatrics, at the University of Melbourne. Her research program focuses on optimising antimicrobial use and access in children and includes national and international clinical trials, pharmacokinetic/pharmacodynamic studies, and cohort studies. Amanda is passionate about improving medication use in children and is involved in several international guideline/expert groups (European Society for Paediatric Infectious Diseases, WHO, Therapeutic Guidelines).